La Vonda R. De Witt

As in-house counsel for Glaxo Wellcome (now GlaxoSmithKline) and Merck & Company, La Vonda counseled clients on global strategies for protecting new discoveries for oncology, cardiovascular and anti-inflammatory therapeutic agents (Glaxo) and antibiotic therapeutic agents (Merck). As outside counsel, La Vonda also has a proven track-record of successfully counseling key stakeholders on the procurement, management and defense of chemical and life sciences-related patents.